| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $38K-56.1% | $86K-56.7% | $199K-2.2% | $203K-64.7% | $576K+34.6% | $428K |
| Cost of revenue | $60K-35.3% | $93K-41.8% | $161K-21.0% | $203K-64.7% | $576K+34.6% | $428K |
| Gross loss | -$23K-207.4% | -$7K-119.3% | $38K | $0 | $0 | $0 |
| Research and development | $6.0M-2.6% | $6.2M+8.1% | $5.7M+70.6% | $3.4M+74.6% | $1.9M+12.0% | $1.7M |
| General and administrative | $3.8M+4.4% | $3.6M+2.1% | $3.5M+13.1% | $3.1M+29.7% | $2.4M+4.4% | $2.3M |
| Sales and marketing | $1.1M-12.1% | $1.2M+12.1% | $1.1M+30.7% | $852K+66.2% | $513K+1182.0% | $40K |
| Total operating expenses | $10.9M-1.4% | $11.1M+6.5% | $10.4M+41.5% | $7.3M+51.4% | $4.8M+19.2% | $4.1M |
| Loss from operations | -$10.9M+1.2% | -$11.1M-6.9% | -$10.4M-41.0% | -$7.3M-51.4% | -$4.8M-19.2% | -$4.1M |
| Interest income, net | $355K-45.7% | $653K+64.1% | $398K+159.1% | $154K+1309.4% | -$13K | — |
| Net loss | -$10.6M-1.5% | -$10.4M-4.7% | -$10.0M-38.5% | -$7.2M-50.7% | -$4.8M+38.8% | -$7.8M |
| Net loss per share – basic and diluted (in dollars per share) | -$1.16+9.4% | -$1.28+20.5% | -$1.61-37.6% | -$1.17-46.2% | -$0.80+63.6% | -$2.20 |
| Weighted average number of shares outstanding – basic and diluted (in shares) | 9.1M+11.9% | 8.2M+31.9% | 6.2M+0.5% | 6.2M+3.7% | 5.9M+67.8% | 3.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.